pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Diacomit
drug
save

stiripentol

Marketedupdated 3mo ago
by Biocodex
Approved
community read0 votes

🐶 often sniffed alongside

top 8
  • drugDIACOMIT26 co-mentions · 8 sources
  • tagApproval24 co-mentions · 6 sources
  • companyBiocodex12 co-mentions · 6 sources
  • tagSmall Molecule12 co-mentions · 6 sources
  • tagOncology6 co-mentions · 1 sources
  • companyLife Science OHFC1 co-mentions · 1 sources
  • companySun Yat-sen University Hospital Seven1 co-mentions · 1 sources
  • tagNephrology1 co-mentions · 1 sources

all catalysts(8)

approval · 6
Aug 20, 2018
approval
8y ago
DIACOMIT (STIRIPENTOL) — FDA approval
stiripentol
→
Aug 20, 2018
approval
8y ago
DIACOMIT (STIRIPENTOL) — FDA approval
stiripentol
→
Jul 14, 2022
approval
4y ago
DIACOMIT (STIRIPENTOL) — FDA approval
stiripentol
→
Jul 14, 2022
approval
4y ago
DIACOMIT (STIRIPENTOL) — FDA approval
stiripentol
→
Apr 15, 2026
approval
4mo ago
DIACOMIT (STIRIPENTOL) — FDA approval
stiripentol
→
Apr 15, 2026
approval
4mo ago
DIACOMIT (STIRIPENTOL) — FDA approval
stiripentol
→
phase 1 completion · 2
Apr 30, 2026
phase 1 completion
4mo ago
Life Science OHFC — stiripentol (Phase I Trial Completion)
stiripentol
→
Apr 30, 2026
phase 1 completion
4mo ago
Sun Yat-sen University Hospital Seven — stiripentol (Phase I Trial Completion)
stiripentol
→
view all 8 catalysts →

Trials studying stiripentol

  • phase1Bioavailability of Stiripentol After Single Oral Dose of Capsule vs Suspension in Healthy Subjects (STILIQ)completedn=24
  • phase1Pharmacokinetic Parameters of Stiripentol in Renal Impaired Patients and Matching Controls With Normal Renal Functioncompletedn=39
  • phase4Study of Interest of Stiripentol and Carbamazepine in the Treatment of Patients With Pharmacoresistant Focal Epilepsiescompletedn=52
  • phase3Evaluation of the Efficacy and Safety of Stiripentol in Patients 6 Years and Older With Primary Hyperoxaluria Type 1, 2 or 3not yet recruitingn=42

Patent cliff

source: FDA Orange Book
first barrier falls
Jul 14, 2029
~2.9 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

FDA exclusivities (4)

  • Jul 14, 2029ODE-403Orphan Drug (7y)2.9y
  • Jul 14, 2029ODE-403Orphan Drug (7y)2.9y
  • Jul 14, 2029ODE-403Orphan Drug (7y)2.9y
  • Jul 14, 2029ODE-403Orphan Drug (7y)2.9y

News(0)

no news has mentioned this drug yet

brand
Diacomit
generic
stiripentol
indication
Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy)
phase
marketed
Data sources
openFDA · ClinicalTrials.gov
last refreshed 14m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?